Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) " cachexia-anorexia in chronic wasting diseases" and " nutrition in geriatrics"

Clinical Nutrition

Volumn 29, Issue 2, 2010, Pages 154-159

  Muscaritoli, M ^a   Anker, S D ^b   Argiles J ^c   Aversa, Z ^a   Bauer, J M ^d   Biolo, G ^e   Boirie, Y ^f   Bosaeus, I ^g   Cederholm, T ^h   Costelli, P ⁱ   Fearon, K C ^j   Laviano, A ^a   Maggio, M ^k   Fanelli, F Rossi ^a   Schneider, S M ^l   Schols, A ^m   Sieber, C C ^d  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF BARCELONA   (Spain)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^e UNIVERSITY OF TRIESTE   (Italy)

^f INRA and University of Auvergne   (France)

^g SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^h UPPSALA UNIVERSITY   (Sweden)

ⁱ UNIVERSITY OF TURIN   (Italy)

^j UNIVERSITY OF EDINBURGH   (United Kingdom)

^k UNIVERSITY OF PARMA   (Italy)

^l INSERM   (France)

^m MAASTRICHT UNIVERSITY   (Netherlands)

more..

Author keywords

Aging; Anorexia; Cachexia; Chronic diseases; Pre cachexia; Sarcopenia

Indexed keywords

AGING; ANOREXIA; ARTICLE; BODY COMPOSITION; CACHEXIA; CHRONIC WASTING DISEASE; CONSENSUS DEVELOPMENT; DIFFERENTIAL DIAGNOSIS; GERIATRIC CARE; HUMAN; INFLAMMATION; MALNUTRITION; MORBIDITY; MORTALITY; MUSCLE ATROPHY; NUTRITIONAL STATUS; OBESITY; PATHOGENESIS; PROFESSIONAL KNOWLEDGE; QUALITY OF LIFE; WEIGHT REDUCTION;

AGING; ANOREXIA; BODY COMPOSITION; CACHEXIA; CONSENSUS; DIAGNOSIS, DIFFERENTIAL; EARLY DIAGNOSIS; HUMANS; MUSCLE STRENGTH; NUTRITION ASSESSMENT; OVERWEIGHT; SARCOPENIA; SEVERITY OF ILLNESS INDEX; TERMINOLOGY AS TOPIC;

EID: 77950340105     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2009.12.004     Document Type: Article

References (71)

1. Norman K., Pichard C., Lochs H., Pirlich M. Prognostic impact of disease-related malnutrition. Clin Nutr 2008, 27:5-15.
2. Doehner W., Anker S.D. Cardiac cachexia in early literature: a review of research prior to Medline. Int J Cardiol 2002, 85:7-14.
3. Delano M.J., Moldawer L.L. The origins of cachexia in acute and chronic inflammatory diseases. Nutr Clin Pract 2006, 21(1):68-81.
4. Akner G., Cederholm T. Treatment of protein-energy malnutrition in chronic nonmalignant disorders. Am J Clin Nutr 2001, 74(1):6-24.
5. Meier R., Stratton R.J. Epidemiology of malnutrition. Basics in clinical nutrition 2004, 31-37. Galen. 3rd ed. L. Sobotka (Ed.).
6. Stratton R.J., Hackston A., Longmore D., Dixon R., Price S., Stroud M., et al. Malnutrition in hospital outpatients and inpatients: prevalence, concurrent validity and easy of use of the " malnutrition universal screening tool" (MUST) for adults. Br J Nutr 2004, 92(5):799-808.
7. Kondrup J., Allison S.P., Elia M., Vellas B., Plauth M. ESPEN guidelines for nutrition screening 2002. Clin Nutr 2003, 22:415-421.
8. Stratton R.J. Should food or supplements be used in the community for the treatment of disease related malnutrition?. Proc Nutr Soc 2005, 64(3):325-333.
9. Muscaritoli M., Bossola M., Aversa Z., Bellantone R., Rossi Fanelli F. Prevention and treatment of cancer cachexia: new insights into an old problem. Eur J Cancer 2006, 42:31-41.
10. Laviano A., Meguid M.M., Inui A., Muscaritoli M., Rossi Fanelli F. Therapy insight: cancer anorexia-cachexia syndrome: when all you can eat is yourself. Nat Clin Pract Oncol 2005, 2(3):158-165.
11. Rosenberg I. Summary comments. Am J Clin Nutr 1989, 50:1231-1233.
12. Roubenoff R. Origins and clinical relevance of sarcopenia. Can J Appl Physiol 2001, 26(1):78-89.
13. Janssen I., Heymsfield S.B., Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 2002, 50:889-896.
14. Evans W.J. What is sarcopenia?. J Gerontol A Biol Sci Med Sci 1995, 50. Spec:5-8.
15. Pahor M., Kritchevsky S. Research hypotheses on muscle wasting, aging, loss of function and disability. J Nutr Health Aging 1998, 2:97-100.
16. Castaneda C., Charnley J.M., Evans W.J., Crim M.C. Elderly women accommodate to a low-protein diet with losses of body cell mass, muscle function, and immune response. Am J Clin Nutr 1995, 62:30-39.
17. Baumgartner R.N., Koehler K.M., Gallagher D., Romero L., Heymsfield S.B., Ross R.R., et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998, 147:755-763.
18. Schneider S.M., Al-Jaouni R., Filippi J., Wiroth J.B., Zeanandin G., Arab K., et al. Sarcopenia is prevalent in patients with Crohn's disease in clinical remission. Inflamm Bowel Dis 2008, 14:1562-1568.
19. Kamel H.K. Sarcopenia and aging. Nutr Rev 2003, 61:157-167.
20. Joseph C., Kenny A.M., Taxel P., Lorenzo J.A., Duque G., Kuchel G.A. Role of endocrine-immune dysregulation in osteoporosis, sarcopenia, frailty and fracture risk. Mol Aspects Med 2005, 26:181-201.
21. Guralnik J.M., Ferrucci L., Pieper C.F., Leveille S.G., Markides K.S., Ostir G.V., et al. Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A Biol Sci Med Sci 2000, 55:M221-M231.
22. Evans W.J., Morley J.E., Argilés J., Bales C., Baracos V., Guttridge D., et al. Cachexia: a new definition. Clin Nutr 2008 Dec, 27(6):793-799.
23. Bistrian B. Systemic response to inflammation. Nutr Rev 2007, 65(12 Pt 2):S170-S172.
24. Fearon K.C., Voss A.C., Hustead D.S. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 2006, 83(6):1345-1350. Cancer Cachexia Study Group.
25. Argiles J.M., Lopez-Soriano F.J. Catabolic proinflammatory cytokines. Curr Opin Clin Nutr Metab Care 1998, 1:245-251.
26. Walsh D., Mahmoud F., Barna B. Assessment of nutritional status and prognosis in advanced cancer: interleukin-6, C-reactive protein, and the prognostic and inflammatory nutritional index. Support Care Cancer 2003 Jan, 11(1):60-62.
27. Deans C., Wigmore S.J. Systemic inflammation, cachexia and prognosis in patients with cancer. Curr Opin Clin Nutr Metab Care 2005, 8:265-269.
28. Lochs H., Allison S.P., Meier R., Pirlich M., Kondrup J., Scheider S., et al. Introductory to the ESPEN guidelines on Enteral Nutrition: Terminology, Definitions and General topics. Clin Nutr 2006, 25:180-186.
29. Stratton R.J., Green C.J., Elia M. Disease-related malnutrition: an evidence-based approach to treatment 2003, CABI Publishing, Oxon, UK, p. 3.
30. Laviano A., Meguid M.M., Rossi Fanelli F. Cancer anorexia: clinical implications, pathogenesis, and therapeutic strategies. Lancet Oncol 2003, 4:686-694.
31. Friedman L.S., Isselbacher K.J. Anorexia, nausea, vomiting, and indigestion. Harrison's principles of internal medicine 1991, McGraw-Hill Inc., New York. 12th ed. J.D. Wilson, E. Braunwald, K.J. Isselbacher, R.G. Petersdorf, J.B. Martin, A.S. Fauci, R.K. Root (Eds.).
32. Hiesmayr M, Schindler K, Pernicka E, Schuh C, Schoeniger-Hekele A, Bauer P, et al. Decreased food intake is a risk factor for mortality in hospitalized patients: The Nutrition Day Survey 2006. Clin Nutr 2009;28(5): 484-91.
33. Kalantar-Zadeh K., Block G., McAllister C.J., Humphreys M.H., Kopple J.D. Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr 2004, 80:299-307.
34. Ribaudo J.M., Cella D., Hahn E.A., Lloyd S.R., Tchekmedyian N.S., Von Roenn J., et al. Re-validation and shortening of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT) questionnaire. Qual Life Res 2000, 9:1137-1146.
35. National Institute of Health Interactive Textbook on Clinical Symptom Research Available at, accessed Sept 22. http://symptomresearch.nih.gov.
36. Burrowes J.D., Larive B., Chertow G.M., Cockram D.B., Dwyer J.T., Greene T., et al. Self-reported appetite, hospitalization and death in haemodialysis patients: findings from the Hemodialysis (HEMO) Study. Nephrol Dial Transplant 2005, 20:2765-2774.
37. Rossi Fanelli F., Cangiano C., Ceci F., Cellerino R., Franchi F., Menichetti E.T., et al. Plasma tryptophan and anorexia in human cancer. Eur J Cancer Clin Oncol 1986, 22:89-95.
38. Muscaritoli M., Molfino A., Chiappini M.G., Laviano A., Ammann T., Spinsanti P., et al. Anorexia in hemodialysis patients: the possible role of des-acyl ghrelin. Am J Nephrol 2007, 27:360-365.
39. Cangiano C., Testa U., Muscaritoli M., Meguid M.M., Mulieri M., Laviano A., et al. Cytokines, tryptophan and anorexia in cancer patients before and after surgical tumor ablation. Anticancer Res 1994, 14:1451-1455.
40. Laviano A., Cangiano C., Preziosa I., Riggio O., Conversano L., Cascino A., et al. Plasma tryptophan levels and anorexia in liver cirrhosis. Int J Eat Disord 1997, 21:181-186.
41. Walsh D., Rybicki L., Nelson K.A., Donnelly S. Symptoms and prognosis in advanced cancer. Support Care Cancer 2002, 10:385-388.
42. Tisdale M.J. Clinical anticachexia treatment. Nutr Clin Pract 2006, 21(2):168-174.
43. Devaraj S., O'Keefe G., Jial I. Defining the proinflammatory phenotype using high sensitive C-reactive protein levels as the biomarker. J Clin Endocr 2005, 90(8):4549-4554.
44. Black S., Kushner I., Samols D. C-reactive protein. J Biol Chem 2004, 279(47):48487-48490.
45. World Health Organization: Diabetes mellitus: report of a WHO study group 1985, World Health Organization, Geneva, Tech.RepSer., no 727.
46. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2006, 29:S43-S48.
47. Pichard C. Body composition measurements during wasting diseases. Curr Opin Clin Nutr Metab Care 1998, 1(4):357-361.
48. Barendregt K., Soeters P.B., Allison S.P., Sobotka L. Simple and stress starvation. Clinical nutrition 2004, 107-113. Galen. 3rd ed. L. Sobotka (Ed.).
49. von Haehling S., Doehner W., Anker S.D. Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure. Cardiovasc Res 2007, 73(2):298-309.
50. Schols A., Broekhuizen R., Weling-Scheepers C.A., Wouters E.F. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005, 82:53-59.
51. Mantovani G. Cachexia related to multiple cause. Cachexia and wasting: a modern approach 2006, 161-162. Springer. G. Mantovani (Ed.).
52. Costelli P., Baccino F.M. Mechanisms of skeletal muscle depletion in wasting syndromes: role of ATP-ubiquitin-dependent proteolysis. Curr Opin Clin Nutr Metab Care 2003, 6(4):407-412.
53. Goldspink G. Impairment of IGF-I gene splicing and MGF expression associated with muscle wasting. Int J Biochem Cell Biol 2006, 38(3):481-489.
54. Costelli P., Muscaritoli M., Bossola M., Penna F., Reffo P., Bonetto A., et al. IGF-1 is downregulated in experimental cancer cachexia. Am J Physiol Regul Integr Comp Physiol 2006, 291(3):R674-R683.
55. Saini A., Al-Shanti N., Stewart C.E. Waste management - cytokines, growth factors and cachexia. Cytokine Growth Factor Rev 2006, 17(6):475-486.
56. Tisdale M.J. The " cancer cachectic factors" Support Care Cancer 2003, 11(2):73-78.
57. Thomas D.R. Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia. Clin Nutr 2007, 26:389-399.
58. Barendregt K., Soeters P.B., Allison S.P. Influence of malnutrition on physiological function. Basics in clinical nutrition 2004, 18-20. Galen. 3rd ed. L. Sobotka (Ed.).
59. Biolo G., Ciocchi B., Stulle M., Piccoli A., Lorenzon S., Dal Mas V., et al. Metabolic consequences of physical inactivity. J Ren Nutr 2005, 15(1):49-53.
60. Biolo G., Heer M., Narici M., Strollo F. Microgravity as a model of ageing. Curr Opin Clin Nutr Metab Care 2003, 6(1):31-40.
61. Prado C.M., Lieffers J.R., McCargar L.J., Reiman T., Sawyer M.B., Martin L., et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 2008, 9(7):629-635.
62. Stenholm S., Harris T.B., Rantanen T., Visser M., Kritchevsky S.B., Ferrucci L. Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metab Care 2008, 11(6):693-700.
63. Guillet C., Delcourt I., Rance M., Giraudet C., Walrand S., Bedu M., et al. Changes in basal and insulin and amino acid response of whole body and skeletal muscle proteins in obese men. J Clin Endocrinol Metab 2009, 94(8):3044-3050.
64. Biolo G., Agostini F., Simunic B., Sturma M., Torelli L., Preiser J.C., et al. Positive energy balance is associated with accelerated muscle atrophy and increased erythrocyte glutathione turnover during 5wk of bed rest. Am J Clin Nutr 2008 Oct, 88(4):950-958.
65. Hughes V.A., Frontera W.R., Roubenoff R., Evans W.J., Singh M.A. Longitudinal changes in body composition in older men and women: role of body weight change and physical activity. Am J Clin Nutr 2002, 76:473-481.
66. Boirie Y., Gachon P., Cordat N., Ritz P., Beaufrère B. Differential insulin sensitivities of glucose, amino acid, and albumin metabolism in elderly men and women. J Clin Endocrinol Metab 2001 Feb, 86(2):638-644.
67. Guillet C., Prod'homme M., Balage M., Gachon P., Giraudet C., Morin L., et al. Impaired anabolic response of muscle protein synthesis is associated with S6K1 dysregulation in elderly humans. FASEB J 2004, 18:1586-1587.
68. Rasmussen B.B., Fujita S., Wolfe R.R., Mittendorfer B., Roy M., Rowe V.L., et al. Insulin resistance of muscle protein metabolism in aging. FASEB J 2006 Apr, 20(6):768-769.
69. Muscaritoli M., Costelli P., Aversa Z., Bonetto A., Baccino F.M., Rossi Fanelli F. New strategies to overcome cancer cachexia: from molecular mechanisms to the 'Parallel Pathway'. APJCN 2008, 17. S1:387-90.
70. Morley J.E., Thomas D.R., Wilson M.M.G. Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr 2006, 83:735-743.
71. Plauth M., Schütz E.T. Cachexia in liver cirrhosis. Int J Cardiol 2002, 85:83-87.